lisocabtagene maraleucel
bms
['transform,(-transformi),(-transforme),(-transforma),(-transforms),(-transform1),(-transform 1),(-transform-1),(-transform2),(-transform 2),(-transform-2)', 'lymphoma', 'mantle,(-dismantle)', 'lymsm', 'transcend,(-nhl-001),(-nhl 001),(-nhl001),(-nhl-006),(-nhl 006),(-nhl006),(-pilot-017006),(-pilot017006),(-pilot 017006)', 'cml']
dr. contributed to two addn'l #17icml abstracts:
- overall survival adjusting for crossover in transform: - r/r mantle cell lymphoma in transcend: #lymsm #celltherapy #tcellrx cc 
The official account for the @CUMedicalSchool @CUAnschutz Lymphoma Program. #lymsm